Summarizing the obtained data, it would be worth considering the use of DC-based vaccines in therapy, consisting of DC/IL-18 + IL-12/TAg cells, which are characterized by an increased ability to infiltrate tumor tissue, and DC/TAg, which migrated most effectively to the lymph nodes. Here, IL18 is linked to neoplasm.